文献速递类风湿关节炎

系统方法揭示类风湿关节炎中非HLA风险变异与HLA-DRB1风险等位基因之间存在大量交互作用

Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2018-07-02

在抗瓜氨酸化蛋白抗体阳性类风湿关节炎(ACPA阳性RA)的两个独立队列(瑞典EIRA和北美NARAC)中,全基因组水平计算相加交互归因比例(AP),发现HLA-DRB1共享表位(SE)等位基因与疾病相关SNP之间存在显著交互富集,且部分交互SNP为SE等位基因背景下的顺式eQTL。

要点

  • HLA-DRB1 SE等位基因与ACPA阳性RA相关SNP存在显著交互富集(Kolmogorov-Smirnov检验EIRA D=0.35、NARAC D=0.25,均p<2.2e-16)。
  • 两个队列中交互一致的1492个SNP里,564个为显著SE-eQTL。
  • 去除两个顶级交互SNP(rs2476601和rs10739581)的风险等位基因后,HLA-DRB1 SE对疾病的效应量从5.2降至2.5。

核心结论

  • ACPA阳性RA中HLA-DRB1 SE等位基因与非HLA遗传变异之间存在大量遗传交互作用。

研究设计与样本

  • 研究纳入两个独立的ACPA阳性RA队列:瑞典类风湿关节炎流行病学调查(EIRA)和北美类风湿关节炎联盟(NARAC),在全基因组水平计算相加交互的归因比例(AP)。
  • 比较疾病相关SNP与非相关SNP两组间AP p值分布的差异,并评估与HLA-DRB1交互的SNP在ACPA阳性RA患者外周血单核细胞中是否为SE等位基因背景下的顺式eQTL(SE-eQTL)。

主要发现

  • 两个队列中均发现HLA-DRB1 SE等位基因与ACPA阳性RA相关SNP组之间存在显著交互富集(AP p<0.05),Kolmogorov-Smirnov检验EIRA D=0.35、NARAC D=0.25,均p<2.2e-16。
  • 两个队列中交互一致的1492个SNP里,564个为显著SE-eQTL。
  • 去除两个顶级交互SNP(rs2476601和rs10739581)的风险等位基因后,HLA-DRB1 SE对疾病的效应量从5.2降至2.5。

关键数值与推荐

  • 交互显著性阈值:AP p<0.05。
  • 交互富集检验:Kolmogorov-Smirnov检验EIRA D=0.35、NARAC D=0.25,均p<2.2e-16。
  • 两个队列中交互一致的SNP共1492个,其中564个为显著SE-eQTL。
  • HLA-DRB1 SE效应量在去除rs2476601和rs10739581风险等位基因后从5.2降至2.5。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In anti-citrullinated protein antibody positive rheumatoid arthritis (ACPA-positive RA), a particular subset of HLA-DRB1 alleles, called shared epitope (SE) alleles, is a highly influential genetic risk factor. Here, we investigated whether non-HLA single nucleotide polymorphisms (SNP), conferring low disease risk on their own, interact with SE alleles more frequently than expected by chance and if such genetic interactions influence the HLA-DRB1 SE effect concerning risk to ACPA-positive RA. METHODS: We computed the attributable proportion (AP) due to additive interaction at genome-wide level for two independent ACPA-positive RA cohorts: the Swedish epidemiological investigation of rheumatoid arthritis (EIRA) and the North American rheumatoid arthritis consortium (NARAC). Then, we tested for differences in the AP p value distributions observed for two groups of SNPs, non-associated and associated with disease. We also evaluated whether the SNPs in interaction with HLA-DRB1 were cis-eQTLs in the SE alleles context in peripheral blood mononuclear cells from patients with ACPA-positive RA (SE-eQTLs). RESULTS: We found a strong enrichment of significant interactions (AP p<0.05) between the HLA-DRB1 SE alleles and the group of SNPs associated with ACPA-positive RA in both cohorts (Kolmogorov-Smirnov test D=0.35 for EIRA and D=0.25 for NARAC, p<2.2e-16 for both). Interestingly, 564 out of 1492 SNPs in consistent interaction for both cohorts were significant SE-eQTLs. Finally, we observed that the effect size of HLA-DRB1 SE alleles for disease decreases from 5.2 to 2.5 after removal of the risk alleles of the two top interacting SNPs (rs2476601 and rs10739581). CONCLUSION: Our data demonstrate that there are massive genetic interactions between the HLA-DRB1 SE alleles and non-HLA genetic variants in ACPA-positive RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Diaz-Gallo LM, Ramsköld D, Shchetynsky K, et al. Systematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis. Ann Rheum Dis. 2018. PMID: 29967194. doi:10.1136/annrheumdis-2018-213412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。